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New informatics-based work flow paradigms in radiation oncology:
the potential impact on epidemiological cancer research
Andrew Miller
Abstract
Epidemiological research is worthless without verifiable source data. Much of this data is common to the
clinical environment. Currently, substantial resources are allocated to data management bureaucracies in
attempts to ensure data accuracy. These bureaucracies developed in the era of paper records, but in the
present health information climate, the ability to share electronic data presents exciting possibilities, while
placing new responsibilities on the gatherers of information and challenging them to develop new work flow
paradigms. Radiation oncologists have a pivotal role to play in the processing of oncological data for future
epidemiological research because of the substantial overlap in data requirements.
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Introduction
Radiation oncologists are medical specialists who
manage cancer patients and employ radiation therapy
as their main treatment modality. It is estimated that
50% of the patients who are identified in annual cancer incidence records will receive radiation therapy at
some time after their diagnosis; indeed, service planning is often based on this estimate (Delaney et al.
2005).
The speed of infiltration of information technologies
into radiation oncology has been astounding. So rapid
has it been been that while most departments are
equipped with an advanced Oncology Information System (OIS), few are fully aware of the improvements
that can be achieved by a wider implementation that
includes the radiation oncologist's work flow. Coupled
with this under-appreciation is the dearth of experienced implementation services, and the reticence of
oncology administrators to provide the substantial resources required to achieve meaningful implementation.
This paper describes the potential role that radiation oncologists can play in ensuring that data for epidemiological research is accurate and complete. The
impact of the OIS in changing work flow will be discussed in another paper.

Discussion
Current data collection paradigms
There is an unfortunate dichotomy in the handling and
status of current oncological data. In many centres a
single source of data (interaction with a patient) results in dual systems of data flow. This dichotomy results from historical methods of data collection in the
paper era which persist into the electronic era.
The first data flow system consists of 'normal' clinical data which is transmitted within a free text format,
whether stored on paper or electronically. Similar to
all such documentation, this data format is highly explicit, highly variable, largely immutable, difficult to
analyse, poorly structured and unsystematised. The
resultant data repository is prized as the clinical record
but of little additional use.
The second data flow system consists of 'research'
data which is based on the same clinical source but

transmitted within a quantised format; that is, data
that is classified in accordance with strictly defined
categories, such as the National Cancer Institute's
Common Toxicity Criteria. This format is highly implicit, invariable, highly mutable, easy to analyse,
highly structured, systematised and often validated.
To collect and collate this type of oncological data for
research, many departments developed substantial
data 'management' bureaucracies. These systems exist in parallel with and largely duplicate or parasitise
the paper-based process of routine clinical data collection.
While routine data is usually recorded by clinicians
and other staff in a text format, when specialised data
collection is required, an additional process follows
which requires that the identical data be quantised
according to well recognised and validated categories
(e.g., ICD-0 diagnostic codes, AJCC/UICC staging
codes, NCI CTC 99 side effect criteria, RTOG/EORTC
acute toxicity categories, LENT/SOMA scoring). Many
of these categories are now also used in routine practice.
While the source of data is identical (the patient)
and the content is identical, the 'research' collection is
more structured than the 'normal' clinical data. Frequently these categorisations are scored by clinicians
and then transferred to an electronic database by data
managers within the bureaucracy. Moreover, it is not
unknown for data managers to attempt to extract the
quantised data from routine notes. Thus a single clinical interaction results in two essentially contextually
identical but differently structured entries.
Difficulties in the recording of data within the two
systems can be seen when a clinician might, for example, report in the clinical notes that a patient has
‘mild to moderate skin reaction’. However, when entering this as trial data, the entry systems will require
that the assessment of this patient's skin (as a quantised RTOG Acute Skin Reaction) be ‘1’ (meaning faint
erythema, a mild reaction) or ‘2’ (meaning bright erythema, dry desquamation; a moderate reaction), as
there is no ‘1.5 — mild to moderate’ choice.
At sites where there are medical staff with some IT
experience and ability, the tendency has been for
them to build their own individualised but parallel electronic data repositories. These microcosms mirror the
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functionality of the data bureaucracy by being separate from the routine clinical system, often addressing
an area of personal interest. These data repositories
rarely influence normal data recording, or feed back to
correct errors in the clinical record. (It is not unknown
for departments to have all three varieties — routine
clinical, data manager-based and personal data repositories!).
Unfortunately, quality assurance is usually not a
prominent feature of any of these systems. In the first
case, routine clinical data is rarely reviewed or
changed; indeed, in some circumstances, it is considered an offence to alter data. In the second case, the
degree of knowledge required to accurately assure
data resides within medical staff who are largely peripheral to the operations of the bureaucracy. In the
third case, the medical staff member frequently assumes that once the data is collected it is accurate
because it represents a personal endeavour. The
workload to compare multiple data sources with incompatible formats is largely manual and extremely
difficult.
In 'research' cases, data collection is divorced from
the normal stream of clinical activity and the situations
where data are usually collected. Previous attempts to
quality assure these data collections have found errors
of over 20% (Evans et al. 1998; Hobson, Khemani &
Singh, 2005; McCulloch, Ward & Tekkis, 2003; Warsi,
White & McCulloch, 2002). These rates are unacceptable in data used for epidemiological purposes.
Surprisingly, modern oncology is very fortunate because of the widespread tendency to categorise most
of the oncological parameters associated with patients.
This tendency stems from the utility and long tradition
of statistical analysis in determining what strategies
are useful in the management of the cancer patient.
Oncologists therefore are aware of the importance
of data and the formats used in research, but generally have been unable to develop and implement coherent strategies for data collection and verification in
this format within the normal workflow.
The result is the aforementioned circumstance
which conspires to duplicate and divide clinical data.
From the data viewpoint, this may render the majority
of data of little use for epidemiological research. From
the clinical viewpoint, this may compromise the quality
of patient care because the clinician might not have
access to the latest and best data.

Future data collection paradigms
Data collection is a necessary process within each and
every radiation oncology department. Radiation use is
accompanied by a lengthy and detailed audit, with all
Australian and New Zealand radiation oncology departments being required by legislation to collect and
retain the details of the specifications and delivery of
radiation for many years up to and after the death of
the patient. The National Radiation Laboratory of New
Zealand requires that a department should keep a
computerised clinical database. Item 8.2.3 states:
A suitable computerised cancer registry should
be maintained that contains data on radiotherapy
treatments and outcomes of at least the most
common types of cancer. Treatment data should
include details of the radiotherapy (target dose,

fractionation system, etc) together with other
treatment modalities used in combination. Outcome data should include tumour response,
morbidity, mortality, and recurrence. (New Zealand National Radiation Laboratory 1992).

Similar regulatory requirements offer the prospect
of routine data collection that might be provided for
epidemiological research.
The recent availability of the modern OIS has
promised, but not fulfilled, new opportunities for epidemiological research where the implementation of
new systems within radiation oncology departments
based on modern paradigms of data manipulation,
data storage and retrieval will result in better validated and newer forms of data being available
(Chamorro 2001).
The construct that provides the most favourable
conditions for data acquisition for epidemiological research is one where all routine data collection within a
department is based on the quantised data paradigm.
That is, all data is regarded as and collected as if it
were research data. This constitutes a reversal of most
features within current data flows. To achieve this
status, departments should assess software purchases
intended for routine clinical use to discover whether it
contains a repository with categorised data in a quantised format consistent with the type already acquired
by data managers. Such a repository should cover all
required fields and be expandable to include all desired fields within the areas of Record & Verify, Schedule, Document Repository, Clinical Assessments and
Disease & Treatment outcome measures.
The modern oncology department will require that
any newly purchased OIS will also be able to undertake other functionality including scheduling and billing, as well as integrate into the hospital's overall IT
strategy. While the functions that enable the day-today running of the department are important, they are
not the raison d'être or the prime benefit of OIS.
These systems improve efficiency by virtue of their
ability to integrate data, improve workflow and increase safety within the oncology context. Rather than
applying resources to force radiation staff to use a
generic Hospital Information System (HIS) and lose
efficiency in the oncology department, effort should be
expended in establishing data flow between the OIS
and HIS.
The implementation of this new construct requires
reorganisation based on the equally new and important concept of data ownership. The primary aims of
any repository ultimately used for research should be
data coverage (all items completed) and data integrity
(all data makes sense). To achieve this in a normal
clinical workflow requires the inclusion of the concept
of ownership. This is a specifically assigned responsibility for data creation, collection and integrity within
an organisation, rather than an emotional attachment
to the data collection process, or a legal concept.
Once clinical data is discovered (such as the diagnosis), electronic data should be immediately entered
in a quantised format by its owner. This data is then
immediately available for use within the normal clinical
process, and for automated quality reporting to determine whether it is complete and whether it is internally consistent. For example, it should be possible to
use a database report at the end of a clinic to match
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the schedule list of follow-up visits with entries detailing patient follow-up assessments to look for entries
that have not been undertaken or are incomplete. The
data owner can then attend to the correction of the
identified entries.
Of course the determination and assignment of
data to particular groups can be difficult, as this explicit paradigm is not active in many departments and
may cut across an individual's view of their professional standing and function within a system. The
presence of a system of data managers tends to reinforce the view that their data is somehow different to
the normal clinical data. The delegation of data collection to data managers was a pragmatic decision that
occurred when there were no options for electronic
records. This is not the case now and so the decision
to delegate needs to be reassessed. The new OIS
permits a department to reverse this delegation and
redeploy data managers away from data collection and
data entry towards ensuring quality and coverage, and
undertaking analysis.
Nevertheless, the concept of data responsibility
should be associated with frequent quality assurance
of the assigned dataset, looking specifically at completion rate and data coherence, and substituting this
data collection for normal clinical recording. Obviously,
it would be a major undertaking to attempt to quantise all features of the clinical record, however, attempts to isolate areas where quantised data already
exist and cover a major portion of an area should have
early success. Treatment effects is such an area,
where symptomatology is well described (e.g. NCI
Common Toxicity Criteria).
While the proposed changes are substantial, some
of the currently available OISs already possess this
degree of functionality. The size of these software systems is daunting, however, and to expect busy overworked clinical radiation oncologists to undertake the
process of discovery, procedural design and implementation within their work space is wishful thinking.
Unfortunately, other professional groups are equally
unlikely to be successful in undertaking this implementation. Professional implementation services for these
systems are difficult to find, as implementation requires a high degree of knowledge about the radiation
oncologist's work patterns and data use, the software
design and its operational features. The result of purchasing implementation services should be a coherent
system designed to deliver data of research quality
while achieving similar clinical outcomes, and, it is
hoped, with less effort. Implementation costs are built
into other software projects (e.g., PACS introduction),
however there has been no similar process considered
in radiation oncology. Estimating the cost of implementation is difficult, but personal communications
suggest that implementation costs are similar to or in
excess of the purchase cost of the software.
Some of the methodologies required to reconcile
and integrate these systems into current practice will
be the subject of a later article.
There are distinct advantages in the linking of
these patterns of prospective data collection within a
computerised clinical system if the methodologies of
collection are synchronised with the desire to reuse
the data to answer research questions. Other benefits
accrue from this approach. There have already been

calls for retrospective practice reviews of patient outcomes to be subject to the same ethics committee approval process as prospective trials (Lertsithichai
2005). Where the quantising and storage of clinical
data uses nationally approved and internationally recognised codes in a process of continuous prospective
data collection to replace the usual text-based clinical
record, there are no requirements for approval by ethics and professional bodies, or to ask a patient's consent to keep a record, or indeed, to even inform them
of the record.
This approach is based on the fact that the generation of a clinical record is necessary in all medical
situations; however, the format of such a record is not
mandated by legislation. When reporting on the information within the database, confidentiality can be
maintained by use of the unique database number assigned to each patient, which has no relationship to
the Medical Record Number, and by the ability to include relevant patients in a report without actually
opening the patient's record. In a well designed system, assiduous, frequent and early quality assurance
of the entered data will negate the need to individually
review charts.
Data security and storage can be integrated within
a hospital's IT initiatives. Although the OIS is a separate system, its data can be freely exchanged with the
HIS or any other database through common formats
(e.g., NSW Department of Health Radiotherapy Information Strategy where waiting time data is reported
directly from the OIS, and where a minimum dataset
of diagnostic and therapy data is reported to the NSW
Cancer Registry) so that the process engineering
benefiting the oncology department is used while the
requirement for data accumulation within the HIS is
also met. The resultant system does not require the
generation of paper forms except as mandated by
regulation.

Conclusion
There is a surfeit of data collected within normal clinical radiation oncology using outdated text-based
methods that result in repositories of largely unusable
data. Implementation of a modern electronic OIS that
stores data in quantised formats (e.g., NCI Common
Toxicity Criteria) will enable routine clinical data to
achieve a status similar to current research data.
The paradigm of data ownership with its attendant
quality assurance implications can be used to construct a system which is able to ensure data coverage
and integrity. Transfer of this routine data can provide
epidemiological agencies with oncological data with a
high degree of clinical assurance.
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